Skip to content

Liver Fat Content and Bariatric Surgery

Evaluation of Changes in Liver Fat Content and Exploration of Potential Effect Actors After Bariatric Surgery Based on MRI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06064240
Enrollment
50
Registered
2023-10-03
Start date
2022-05-01
Completion date
2025-10-01
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery, Magnetic Resonance Imaging, Non-Alcoholic Fatty Liver Disease

Brief summary

On the basis of previous research, this subject intends to evaluate the liver improvement of patients with liver disease after weight loss by MRI, and quantify it by extracting features, so as to provide a new method to judge the liver status of patients with liver disease, and to evaluate the correlation between the inflammatory status of patients and the quantitative features of MRI, and try to explain the reasons for the improvement of fatty liver status of patients with liver disease after weight loss. To provide a new theoretical basis for fatty liver and systemic inflammatory liver damage in patients with liver disease after weight loss surgery, and to link them, and try to explain the improvement of fatty liver in patients with liver disease through the reduction of systemic inflammatory level.

Detailed description

This study is a prospective study to explore the improvement of fatty liver and severe state of the whole body in patients with liver disease undergoing weight-loss surgery. The research object is obese patients who underwent laparoscopic sleeve gastrectomy in our hospital. According to the standard of accepting the discharge, about 50 patients were selected and divided into groups according to preoperative, postoperative one month, postoperative three months and postoperative six months.All patients underwent routine sequence examinations using a Siemens 3.0T MRI scanner (MAGNETOM Prisma, Siemens Healthcare, Munich, Germany).This study investigates alterations in NAFLD among patients with obesity who underwent bariatric surgery using MRI-PDFF and MRS techniques. Additionally, we evaluated the factors that may influence these changes in patients after the surgical procedure.

Interventions

OTHERWe do not have any intervention type

We do not have any intervention type

Sponsors

yu li,MD
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 16 years old \< age \< 60 years old * BMI \> 32kg/m2 * No previous drinking history; weekly drinking of males \< 210g and females \< 140g in 12 months * Preoperative auxiliary examination supports the diagnosis of fatty liver, and liver MRI examination * Previous attempts to lose weight are ineffective * Complete case data.

Exclusion criteria

* Secondary obesity * History of drinking or excessive drinking (in the past 12 months, male's weekly alcohol intake was ≥210g, female's weekly alcohol intake was ≥ 140g) * Other diseases causing abnormal liver function * Body mass index \< 28kg/m2 * Poor compliance or self-control, unable to follow the dietary guidance after operation * Those who cannot complete the follow-up

Design outcomes

Primary

MeasureTime frameDescription
Liver fat fractionbefore surgery、one 、three、six month after surgeryThe primary outcome was a indicator for evaluating liver fat content.
white blood cellbefore surgery、one 、three、six month after surgeryThe primary outcome was a indicator for evaluating inflammation.
aspartate aminotransferasebefore surgery、one 、three、six month after surgeryThe primary outcome was a indicator for evaluating liver function.
alanine aminotransferasebefore surgery、one 、three、six month after surgeryThe primary outcome was a indicator for evaluating liver function.
C-reactive proteinbefore surgery、one 、three、six month after surgeryThe primary outcome was a indicators for evaluating inflammation.
neutrophile granulocytebefore surgery、one 、three、six month after surgeryThe primary outcome was a indicator for evaluating inflammation.

Secondary

MeasureTime frameDescription
low-density lipoproteinbefore surgery、one 、three、six month after surgeryThe secondary outcome was a indicator for evaluating blood fat.
high-density lipoproteinbefore surgery、one 、three、six month after surgeryThe secondary outcome was a indicator for evaluating blood lipid.
glucosebefore surgery、one 、three、six month after surgeryThe secondary outcome was a indicator for evaluating blood glucose.

Other

MeasureTime frameDescription
Body Mass Indexbefore surgery、one 、three、six month after surgeryThe pre-specified outcome was a indicator for evaluating effectiveness of bariatric surgery.

Countries

China

Contacts

Primary Contactyu li, Dr
liyu11920@hotmail.com18661809631
Backup Contactxin li, Dr
15065327781

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026